摘要
评估氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的效果。选取200例确诊为高血压合并冠心病的患者为研究对象,随机将患者分为两组,分别为单一治疗组和联合治疗组,单一治疗组实施常规治疗,联合治疗组实施氨氯地平联合阿托伐他汀钙片治疗,对比两组患者治疗效果。结果显示,联合治疗方案在控制患者血压和管理患者胆固醇水平方面优势明显。研究发现,氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的效果显著,但在应用时需密切监测患者潜在的不良反应,以确保患者安全。此外,为提高治疗的整体效果和患者治疗依从性,医务工作者还需深入探讨其背后的机制以及进行进一步研究。
Evaluate the efficacy of amlodipine combined with atorvastatin calcium tablets in the treatment of hypertension with coronary heart disease.200 patients diagnosed with hypertension combined with coronary heart disease were selected as the research subjects and randomly divided into two groups:a single treatment group and a combination treatment group.The single treatment group received routine treatment,while the combination treatment group received amlodipine combined with atorvastatin calcium tablets for treatment.The treatment effects of the two groups of patients were compared.The results show that the combination therapy has significant advantages in controlling patient blood pressure and managing patient cholesterol levels.Research has found that the combination of amlodipine and atorvastatin calcium tablets has a significant effect on the treatment of hypertension combined with coronary heart disease.However,close monitoring of potential adverse reactions in patients is necessary to ensure their safety during application.In addition,in order to improve the overall effectiveness of treatment and patient compliance,medical workers need to further explore the underlying mechanisms and conduct further research.
作者
袁保军
Yuan Baojun(Heyuan Huaxin Taikang Hospital,Heyuan,Guangdong 517139)
出处
《科技与健康》
2023年第18期57-60,共4页
Technology and Health
关键词
氨氯地平
阿托伐他汀钙片
高血压
冠心病
联合治疗
amlodipine
atorvastatin calcium tablets
hypertension
coronary heart disease
combined therapy
